CIK 0001858685 · <br>Emerging growth company
Biofrontera Inc.
Sign in to watch- Tickers
- BFRI BFRIW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473765675
- Phone
- 781-245-1325
- Business address
- 120 PRESIDENTIAL WAY,, SUITE 330, WOBURN, MA, 01801
Securities
- BFRI Common Stock Nasdaq
- BFRIW Common stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-28 | Luebbert Hermann CEO & Chairman | Option exercise | +62,500 | 352,711 | ||
| 2026-07-28 | Luebbert Hermann CEO & Chairman | Option exercise · Restricted Stock Units | −62,500 | 62,500 | ||
| 2026-07-28 | Leffler Eugene Frederick Chief Financial Officer | Option exercise | +31,250 | 206,250 | ||
| 2026-07-28 | Leffler Eugene Frederick Chief Financial Officer | Option exercise · Restricted Stock Units | −31,250 | 31,250 | ||
| 2026-03-05 | Luebbert Hermann CEO & Chairman | Option exercise | +137,500 | 290,211 | ||
| 2026-03-05 | Luebbert Hermann CEO & Chairman | Option exercise · Restricted Stock Units | −137,500 | 0 | ||
| 2026-03-05 | Leffler Eugene Frederick Chief Financial Officer | Option exercise | +87,500 | 175,000 | ||
| 2026-03-05 | Leffler Eugene Frederick Chief Financial Officer | Option exercise · Restricted Stock Units | −87,500 | 0 | ||
| 2026-03-04 | Weber Kevin Daniel Director | Grant or award · Employee stock option (right to buy) | +20,000 | 20,000 | ||
| 2026-03-04 | Luebbert Hermann CEO & Chairman | Grant or award · Restricted Stock Units | +125,000 | 125,000 | ||
| 2026-03-04 | Luebbert Hermann CEO & Chairman | Grant or award · Employee stock option (right to buy) | +125,000 | 125,000 | ||
| 2026-03-04 | Leffler Eugene Frederick Chief Financial Officer | Grant or award · Restricted Stock Units | +62,500 | 62,500 | ||
| 2026-03-04 | Leffler Eugene Frederick Chief Financial Officer | Grant or award · Employee stock option (right to buy) | +62,500 | 62,500 | ||
| 2026-03-04 | Lanckriet Heikki Director | Grant or award · Employee stock option (right to buy) | +20,000 | 20,000 | ||
| 2026-03-04 | Hoffman Beth J. Director | Grant or award · Employee stock option (right to buy) | +20,000 | 20,000 | ||
| 2026-03-04 | Jones George Patrick Chief Commercial Officer | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2026-03-04 | Jones George Patrick Chief Commercial Officer | Grant or award · Employee stock option (right to buy) | +50,000 | 50,000 | ||
| 2026-03-04 | BORER JOHN J III Director | Grant or award · Employee stock option (right to buy) | +20,000 | 20,000 | ||
| 2025-09-16 | Biofrontera AG Director | Purchase · Series D Convertible Preferred Stock | +3,019 | 3,019 | ||
| 2025-09-15 | Jones George Patrick Chief Commercial Officer | Grant or award · Employee stock option (right to buy) | +100,000 | 100,000 |
Page 1 of 4 · 71 trades